National Academy of Medicine Elects New Members

Get Permission

Otis Webb Brawley, MD, MACP, FASCO, FACE

Napoleone Ferrara, MD

Amato J. Giaccia, PhD

Gary Gilliland, MD, PhD

Michael R. Green, MD, PhD

Beth Y. Karlan, MD

Kenneth W. Kinzler, PhD

Nikola P. Pavletich, PhD

Alexander Rudensky, PhD

Nahum Sonenberg, PhD

The National Academy of Medicine (NAM), formerly the Institute of Medicine, announced the election of 70 regular members and 10 international members during its Annual Meeting October 19.  Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.  This is the inaugural Annual Meeting as the National Academy of Medicine and the 45th year since the establishment of the Institute of Medicine.

New members are elected by current active members through a selective process that recognizes individuals who have made major contributions to the advancement of the medical sciences, health care, and public health. A diversity of talent among NAM’s membership is assured by its Articles of Organization, which stipulate that at least one-quarter of the membership is selected from fields outside the health professions—for example, from such fields as law, engineering, social sciences, and the humanities. The newly elected members raise NAM’s total active membership to 1,826, and the number of international members to 137.

Ten of the newly inducted members are specialists in the field of oncology:

  • Otis Webb Brawley, MD, MACP, FASCO, FACE, Professor of Hematology, Medical Oncology, Medicine, and Epidemiology, Emory University; and Chief Medical Officer, American Cancer Society, Atlanta
  • Napoleone Ferrara, MD, Distinguished Professor of Pathology and Ophthalmology, University of California, San Diego
  • Amato J. Giaccia, PhD, Jack, Lulu, and Sam Willson Professor of Cancer Biology, Department of Radiation Oncology, Stanford University School of Medicine
  • Gary Gilliland, MD, PhD, President and Director, Fred Hutchinson Cancer Research Center
  • Michael R. Green, MD, PhD, Investigator, Howard Hughes Medical Institute; and Director, Cancer Center, and Professor and Chair, Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School
  • Beth Y. Karlan, MD, Professor, Obstetrics and Gynecology; Director, Women’s Cancer Program, Samuel Oschin Comprehensive Cancer Institute; and Director, Division of Gynecologic Oncology, Cedars-Sinai Medical Center
  • Kenneth W. Kinzler, PhD, Professor of Oncology; Director, Ludwig Center; and Associate Director of Basic Research, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
  • Nikola P. Pavletich, PhD, Investigator, Howard Hughes Medical Institute; and Stephen and Barbara Friedman Chair, Structural Biology Program, Memorial Sloan Kettering Cancer Center
  • Alexander Rudensky, PhD, Investigator, Howard Hughes Medical Institute; and Chairman, Immunology Program, and Director, Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center
  • Nahum Sonenberg, PhD, James McGill Professor, Department of Biochemistry and Rosalind and Morris Goodman Cancer Research Centre, McGill University

For a full list of newly elected members, visit  ■